Erlic, Z.
13  Ergebnisse:
Personensuche X
?
2

Neurofibromatosis type 1: should we screen for other geneti..:

Gkaliagkousi, E. ; Erlic, Z. ; Petidis, K....
European Journal of Clinical Investigation.  39 (2009)  9 - p. 828-832 , 2009
 
?
 
?
5

Pheocromocytoma/Paraganglioma Syndrome: SDHB, SDHC and SDHD..:

Schiavi, F. ; Trabalzini, F. ; Dematt??, S....
High Blood Pressure & Cardiovascular Prevention.  12 (2005)  3 - p. 161 , 2005
 
?
6

Targeted Metabolomics as a Tool in Discriminating Endocrine..:

Erlic Z ; Reel P ; Reel S...
info:eu-repo/semantics/altIdentifier/pmid/33382876.  , 2021
 
?
7

Targeted metabolomics as a tool in discriminating endocrine..:

Erlic, Z ; Reel, P ; Reel, S...
info:eu-repo/semantics/altIdentifier/doi/10.1210/clinem/dgaa954.  , 2021
 
?
8

Pre- versus post-operative untargeted plasma nuclear magnet..:

Bliziotis, N.G ; Kluijtmans, L.A.J ; Soto, S...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s12020-021-02858-z.  , 2021
 
?
9

Machine learning-based clinical outcome prediction in surge..:

Zanier O ; Zoli M ; Staartjes V. E...
info:eu-repo/semantics/altIdentifier/pmid/34642894.  , 2021
 
?
10

Metabolic impact of pheochromocytoma/ paraganglioma: Target..:

Erlic, Z ; Kurlbaum, M ; Deutschbein, T...
info:eu-repo/semantics/altIdentifier/doi/10.1530/EJE-19-0589.  , 2019
 
?
12

Junger Patient mit multiplen Paragangliomen:

Brase, C ; Erlic, Z ; Neumann, H..
http://dx.doi.org/10.3205/10hnod014.  , 2010
 
?
13

Development and external validation of clinical prediction ..:

O. Zanier ; M. Zoli ; V.E. Staartjes...
http://www.sciencedirect.com/science/article/pii/S2772529422006804.  , 2022
 
1-13